The function of γ-glutamyl transpeptidase as a determinant in cell sensitivity to AZASERINE (cas 115-02-6) toxicity
-
Add time:08/28/2019 Source:sciencedirect.com
The enzyme γ-glutamyl transpeptidase (GGT) is characteristically present at high levels in mammalian cells that are vulnerable in vivo to the selectively toxic and carcinogenic effects of the naturally occurring diazo amino acid L-AZASERINE (cas 115-02-6). The possible role of GGT as a determinant of cellular sensitivity to azaserine toxicity was investigated. No correlation was found between GGT activity and the abilities of different cell lines or GGT-deficient cell strains of TuWi, a human nephroblastoma-derived line high in GGT, to accumulate azaserine. However, the thiols glutathione and cysteine were found to inhibit the toxicity of azaserine in cultures of TuWi. In addition, maleate lowered both intracellular and extracellular glutathione levels and enhanced sensitivity of TuWi cells to azaserine, while serine-borate, a potent inhibitor of GGT, increased extracellular glutathione levels and inhibited azaserine toxicity. Since extracellular glutathione accumulation, which may reflect the rate of cellular glutathione turnover, is increased in cultures of azaserine-resistant, GGT-deficient strains of TuWi, we propose that GGT enhances cellular sensitivity to azaserine primarily by increasing the rate of glutathione turnover, thus removing the glutathione from detoxification pathways.
We also recommend Trading Suppliers and Manufacturers of AZASERINE (cas 115-02-6). Pls Click Website Link as below: cas 115-02-6 suppliers
Prev:Inhibition by verapamil of cholecystokinin-enhancement of pancreatic carcinogenesis induced by AZASERINE (cas 115-02-6) in Wistar rats
Next:Mutagenicity of O-diazoacetyl-l-serine (AZASERINE (cas 115-02-6)) and 6-diazo-5-oxo-l-norleucine (DON) in a soybean test system) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- AZASERINE (cas 115-02-6): survival and mutation in Escherichia coli08/31/2019
- The stoichiometric fate of AZASERINE (cas 115-02-6) metabolized in vitro by tissues from AZASERINE (cas 115-02-6)-treated dogs and mice☆08/30/2019
- Mutagenicity of O-diazoacetyl-l-serine (AZASERINE (cas 115-02-6)) and 6-diazo-5-oxo-l-norleucine (DON) in a soybean test system08/29/2019
- Inhibition by verapamil of cholecystokinin-enhancement of pancreatic carcinogenesis induced by AZASERINE (cas 115-02-6) in Wistar rats08/27/2019
- Crystal Structures of Escherichia coli γ-Glutamyltranspeptidase in Complex with AZASERINE (cas 115-02-6) and Acivicin: Novel Mechanistic Implication for Inhibition by Glutamine Antagonists08/26/2019
- Inhibition by amiloride of experimental carcinogenesis induced by AZASERINE (cas 115-02-6) in rat pancreas08/25/2019
- The specificity of methionine sulfoximine and AZASERINE (cas 115-02-6) inhibition in plant tissuesIn honour of Professor G. H. Neil Towers 75th birthday08/24/2019
- The LIV-I/LS system as a determinant of AZASERINE (cas 115-02-6) sensitivity of Escherichia coli K-1208/23/2019
- Original ResearchProtective effect of Emilia sonchifolia on AZASERINE (cas 115-02-6)-induced pancreatic dysplasia08/22/2019